Imad Ajjawi, PhD, MBA
Imad has over 15 years of professional experience in the biotech arena, spanning technical, managerial, business development, consulting and entrepreneurial roles. He is the author of numerous patents, manuscripts and grants, resulting in over $60 million in funding through strategic partnerships. Prior to founding Denovium, Imad was part of the corporate business development team at Synthetic Genomics Inc (SGI). He was responsible for out-licensing technology and providing strategic direction to a number of business units including DNA technologies, computational biology, and translational medicine. Earlier during his SGI tenure, Imad was the lead genomics scientist of the Algae Biofuels group. His breakthrough work engineering algae biofuels was published in Nature Biotechnology and featured in numerous prestigious media outlets including WIRED, Forbes, Bloomberg, KPBS and NPR. Imad was a post-doctoral fellow at Michigan State University and earned his PhD in Biochemistry & Molecular Biology from the University of Nevada Reno. He received his MBA from the University of California San Diego.